Literature DB >> 29563954

Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using Dual-Energy X-ray Absorptiometry Scanning.

Catherine Hornby1, Hannah Botfield1, Michael W O'Reilly1,2, Connar Westgate1, James Mitchell1,2,3, Susan P Mollan1,4, Konstantinos Manolopoulos1,2, Jeremy Tomlinson2,5, Alexandra Sinclair1,2,3.   

Abstract

Idiopathic intracranial hypertension (IIH) is strongly associated with obesity. We aimed to utilise dual-energy X-ray absorptiometry (DEXA) to characterise fat distribution, and to evaluate change in fat mass and distribution following weight loss. IIH patients (n = 24) had a similar fat distribution to body mass index (BMI)- and gender-matched obese controls (n = 47). In the IIH cohort, truncal fat mass correlated with lumbar puncture pressure. Weight loss in IIH patients resulted in a significant reduction in disease activity and fat mass, predominantly from the truncal region (-4.40 ± 1.6%; p = 0.008) compared with the limbs (+0.79 ± 6.5%; p = 0.71). These results indicate that, contrary to previous studies using waist-hip ratios, IIH adiposity is centripetal, similar to simple obesity. Future studies should establish the risk of the metabolic syndrome and the role of adipose tissue depot-specific function in IIH.

Entities:  

Keywords:  DEXA; idiopathic intracranial hypertension; obesity

Year:  2017        PMID: 29563954      PMCID: PMC5858863          DOI: 10.1080/01658107.2017.1334218

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  25 in total

1.  Effect of calorie restriction with or without exercise on body composition and fat distribution.

Authors:  Leanne M Redman; Leonie K Heilbronn; Corby K Martin; Anthony Alfonso; Steven R Smith; Eric Ravussin
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

2.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

3.  Effect of weight loss on regional body fat distribution in premenopausal women.

Authors:  M Zamboni; F Armellini; E Turcato; T Todesco; L Bissoli; I A Bergamo-Andreis; O Bosello
Journal:  Am J Clin Nutr       Date:  1993-07       Impact factor: 7.045

4.  Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Authors:  Alexandra J Sinclair; Michael A Burdon; Peter G Nightingale; Alexandra K Ball; Peter Good; Timothy D Matthews; Andrew Jacks; Mark Lawden; Carl E Clarke; Paul M Stewart; Elizabeth A Walker; Jeremy W Tomlinson; Saaeha Rauz
Journal:  BMJ       Date:  2010-07-07

Review 5.  11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

Authors:  Jeremy W Tomlinson; Elizabeth A Walker; Iwona J Bujalska; Nicole Draper; Gareth G Lavery; Mark S Cooper; Martin Hewison; Paul M Stewart
Journal:  Endocr Rev       Date:  2004-10       Impact factor: 19.871

6.  Idiopathic intracranial hypertension is associated with lower body adiposity.

Authors:  Anat Kesler; Efrat Kliper; Galina Shenkerman; Naftali Stern
Journal:  Ophthalmology       Date:  2009-11-13       Impact factor: 12.079

7.  Variable contributions of fat content and distribution to metabolic syndrome risk factors.

Authors:  Scott M Grundy; Beverley Adams-Huet; Gloria Lena Vega
Journal:  Metab Syndr Relat Disord       Date:  2008-12       Impact factor: 1.894

8.  Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss.

Authors:  Jeremy W Tomlinson; Joanne Finney; Beverly A Hughes; Susan V Hughes; Paul M Stewart
Journal:  Diabetes       Date:  2008-03-13       Impact factor: 9.461

9.  Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity.

Authors:  Jeremy W Tomlinson; Joanne Finney; Christopher Gay; Beverly A Hughes; Susan V Hughes; Paul M Stewart
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

Review 10.  Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management.

Authors:  Susan P Mollan; Fizzah Ali; Ghaniah Hassan-Smith; Hannah Botfield; Deborah I Friedman; Alexandra J Sinclair
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-02-17       Impact factor: 10.154

View more
  14 in total

1.  Differing presenting features of idiopathic intracranial hypertension in the UK and US.

Authors:  R J Blanch; C Vasseneix; A Liczkowski; A Yiangou; A Aojula; J A Micieli; S P Mollan; N J Newman; V Biousse; B B Bruce; A Sinclair
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

Review 2.  The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension: Body Weight.

Authors:  Susan P Mollan; Abd A Tahrani; Alexandra J Sinclair
Journal:  Neurol Clin Pract       Date:  2021-08

Review 3.  Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension.

Authors:  Zerin Alimajstorovic; Connar S J Westgate; Rigmor H Jensen; Sajedeh Eftekhari; James Mitchell; Vivek Vijay; Senali Y Seneviratne; Susan P Mollan; Alexandra J Sinclair
Journal:  Eye (Lond)       Date:  2020-01-02       Impact factor: 3.775

4.  The Health Economic Evaluation of Bariatric Surgery Versus a Community Weight Management Intervention Analysis from the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT).

Authors:  Magda Aguiar; Emma Frew; Susan P Mollan; James L Mitchell; Ryan S Ottridge; Zerin Alimajstorovic; Andreas Yiangou; Rishi Singhal; Abd A Tahrani; Alex J Sinclair
Journal:  Life (Basel)       Date:  2021-04-30

5.  Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension.

Authors:  Connar Sj Westgate; Hannah F Botfield; Zerin Alimajstorovic; Andreas Yiangou; Mark Walsh; Gabrielle Smith; Rishi Singhal; James L Mitchell; Olivia Grech; Keira A Markey; Daniel Hebenstreit; Daniel A Tennant; Jeremy W Tomlinson; Susan P Mollan; Christian Ludwig; Ildem Akerman; Gareth G Lavery; Alexandra J Sinclair
Journal:  JCI Insight       Date:  2021-05-24

Review 6.  Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention.

Authors:  Catherine Hornby; Susan P Mollan; Hannah Botfield; Michael W OʼReilly; Alexandra J Sinclair
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

Review 7.  Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension.

Authors:  Sajedeh Eftekhari; Connar Stanley James Westgate; Maria Schmidt Uldall; Rigmor Hoejland Jensen
Journal:  Fluids Barriers CNS       Date:  2019-11-26

Review 8.  Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting.

Authors:  Sam P Gurney; Sateesh Ramalingam; Alan Thomas; Alex J Sinclair; Susan P Mollan
Journal:  Eye Brain       Date:  2020-01-14

9.  11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension.

Authors:  Rowan S Hardy; Hannah Botfield; Keira Markey; James L Mitchell; Zerin Alimajstorovic; Connar S J Westgate; Michael Sagmeister; Rebecca J Fairclough; Ryan S Ottridge; Andreas Yiangou; Karl-Heinz H Storbeck; Angela E Taylor; Lorna C Gilligan; Wiebke Arlt; Paul M Stewart; Jeremy W Tomlinson; Susan P Mollan; Gareth G Lavery; Alexandra J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

10.  Long-term monitoring of intracranial pressure in freely-moving rats; impact of different physiological states.

Authors:  Sajedeh Eftekhari; Connar Stanley James Westgate; Katrine Printz Johansen; Signe Rath Bruun; Rigmor H Jensen
Journal:  Fluids Barriers CNS       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.